Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Steroid-Sparing Effect of Supplemental LCD Treatment in Patients With Moderate-to-Severe Localized Psoriasis Lesions: a Pilot Study.

NCT00769184 is registered in ClinicalTrials.gov with NeoStrata Company, Inc. as lead sponsor.

NCT NCT00769184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Steroid-Sparing Effect of Supplemental LCD Treatment in Patients With Moderate-to-Severe Localized Psoriasis Lesions: a Pilot Study.
Lead sponsor
NeoStrata Company, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2008
Completion date
April 30, 2009
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis